Regional hippocampal atrophy in multiple sclerosis
- PMID: 18375977
- DOI: 10.1093/brain/awn030
Regional hippocampal atrophy in multiple sclerosis
Abstract
Gray matter brain structures, including deep nuclei and the cerebral cortex, are affected significantly and early in the course of multiple sclerosis and these changes may not be directly related to demyelinating white matter lesions. The hippocampus is an archicortical structure that is critical for memory functions and is especially sensitive to multiple insults including inflammation. We used high-resolution MR imaging at 3.0 T to measure hippocampal volumes in relapsing remitting MS (RRMS) and secondary progressive MS (SPMS) patients and controls. We found that both groups of MS patients had hippocampal atrophy and that this volume loss was in excess of global brain atrophy. Subregional analysis revealed selective volume loss in the cornu ammonis (CA) 1 region of the hippocampus in RRMS with further worsening of CA1 loss and extension into other CA regions in SPMS. Hippocampal atrophy was not correlated with T2-lesion volumes, and right and left hippocampi were affected equally. Volume loss in the hippocampus and subregions was correlated with worsening performance on word-list learning, a task requiring memory encoding, but not with performance on the Paced Auditory Serial Addition Task (PASAT), a test of information processing speed. Our findings provide evidence for selective and progressive hippocampal atrophy in MS localized initially to the CA1 subregion that is associated with deficits in memory encoding and retrieval. The underlying histopathological substrate for this selective, symmetric and disproportionate regional hippocampal vulnerability remains speculative at this time. Further understanding of this process could provide targets for therapeutic interventions including neuroprotective treatments.
Similar articles
-
Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.Neuroimage. 2006 Apr 15;30(3):891-8. doi: 10.1016/j.neuroimage.2005.10.032. Epub 2005 Dec 15. Neuroimage. 2006. PMID: 16360321
-
Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.Neuroimage Clin. 2014 Dec 27;8:440-7. doi: 10.1016/j.nicl.2014.12.015. eCollection 2015. Neuroimage Clin. 2014. PMID: 26106524 Free PMC article.
-
Gray matter atrophy in multiple sclerosis: a longitudinal study.Ann Neurol. 2008 Sep;64(3):255-65. doi: 10.1002/ana.21436. Ann Neurol. 2008. PMID: 18661561
-
Cognitive impairment and decline in different MS subtypes.J Neurol Sci. 2006 Jun 15;245(1-2):187-94. doi: 10.1016/j.jns.2005.07.018. Epub 2006 Apr 27. J Neurol Sci. 2006. PMID: 16643951 Review.
-
Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.J Neuroimaging. 2004 Jul;14(3 Suppl):36S-45S. doi: 10.1177/1051228404266267. J Neuroimaging. 2004. PMID: 15228758 Review.
Cited by
-
Analysis of the extent of limbic system changes in multiple sclerosis using FreeSurfer and voxel-based morphometry approaches.PLoS One. 2022 Sep 22;17(9):e0274778. doi: 10.1371/journal.pone.0274778. eCollection 2022. PLoS One. 2022. PMID: 36137122 Free PMC article.
-
Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis.PLoS One. 2012;7(5):e35476. doi: 10.1371/journal.pone.0035476. Epub 2012 May 2. PLoS One. 2012. PMID: 22567104 Free PMC article.
-
Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes.Neurol Ther. 2022 Sep;11(3):1043-1070. doi: 10.1007/s40120-022-00368-2. Epub 2022 Jun 9. Neurol Ther. 2022. PMID: 35680693 Free PMC article. Review.
-
Altered hippocampal GABA and glutamate levels and uncoupling from functional connectivity in multiple sclerosis.Hippocampus. 2018 Nov;28(11):813-823. doi: 10.1002/hipo.23001. Hippocampus. 2018. PMID: 30069963 Free PMC article.
-
Clinical relevance of brain volume measures in multiple sclerosis.CNS Drugs. 2014 Feb;28(2):147-56. doi: 10.1007/s40263-014-0140-z. CNS Drugs. 2014. PMID: 24446248 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous